STA
AMGN icon

Summit Trail Advisors’s Amgen AMGN Stock Holding History

Summit Trail Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.68M Buy
16,148
+2,650
+20% +$945K 0.08% 144
2025
Q4 		$4.42M Sell
13,498
-1,840
-12% -$584K 0.08% 148
2025
Q3 		$4.33M Buy
15,338
+323
+2% +$93.7K 0.06% 167
2025
Q2 		$4.19M Buy
+15,015
New +$4.25M 0.07% 143
2024
Q4 		– Sell
-7,552
Closed -$2.43M – 416
2024
Q3 		$2.43M Buy
7,552
+2,163
+40% +$708K 0.06% 140
2024
Q2 		$1.68M Buy
5,389
+231
+4% +$67.9K 0.04% 162
2024
Q1 		$1.47M Buy
5,158
+425
+9% +$124K 0.04% 166
2023
Q4 		$1.36M Sell
4,733
-233
-5% -$63.5K 0.05% 131
2023
Q3 		$1.33M Buy
4,966
+670
+16% +$167K 0.05% 128
2023
Q2 		$954K Buy
4,296
+1,941
+82% +$450K 0.04% 177
2023
Q1 		$569K Sell
2,355
-283
-11% -$69.5K 0.02% 203
2022
Q4 		$693K Buy
2,638
+255
+11% +$68.4K 0.03% 142
2022
Q3 		$537K Buy
2,383
+574
+32% +$139K 0.03% 167
2022
Q2 		$440K Buy
1,809
+587
+48% +$144K 0.03% 206
2022
Q1 		$295K Sell
1,222
-21
-2% -$4.83K 0.02% 248
2021
Q4 		$280K Sell
1,243
-477
-28% -$101K 0.02% 237
2021
Q3 		$366K Buy
1,720
+326
+23% +$75K 0.03% 185
2021
Q2 		$340K Buy
1,394
+96
+7% +$23.6K 0.03% 165
2021
Q1 		$323K Buy
1,298
+159
+14% +$37.9K 0.03% 150
2020
Q4 		$262K Sell
1,139
-572
-33% -$132K 0.03% 158
2020
Q3 		$406K Buy
1,711
+557
+48% +$138K 0.08% 124
2020
Q2 		$272K Buy
+1,154
New +$263K 0.05% 126
2018
Q4 		– Sell
-1,390
Closed -$288K – 119
2018
Q3 		$288K Buy
+1,390
New +$274K 0.06% 156
2018
Q2 		– Sell
-2,843
Closed -$434K – 490
2018
Q1 		$434K Buy
2,843
+225
+9% +$41.3K 0.07% 226
2017
Q4 		$492K Buy
+2,618
New +$463K 0.06% 231

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Summit Trail Advisors's AMGN Position: Q1 2026 in Review

Summit Trail Advisors increased its Amgen (AMGN) stake by 20% in Q1 2026, buying an estimated $945K and bringing the position to 16,148 shares worth $5.68M. The position accounts for 0.08% of the portfolio, ranked #144.

Summit Trail Advisors first reported a position in AMGN in Q4 2017 and has held it in 25 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Summit Trail Advisors held 16,148 shares of Amgen worth $5.68M as of Q1 2026.
  • Summit Trail Advisors bought 2,650 Amgen shares in Q1 2026, an estimated $945K.
  • Amgen made up 0.08% of Summit Trail Advisors's portfolio in Q1 2026, its #144 holding.
  • Summit Trail Advisors first reported a position in Amgen in Q4 2017 and has held it in 25 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.